Skip to main content

Advertisement

Log in

Efficacy of glutathione mesotherapy in burns: an experimental study

  • Original Article
  • Published:
European Journal of Trauma and Emergency Surgery Aims and scope Submit manuscript

Abstract

Background

Thermal burns are the leading cause of trauma worldwide. Currently, no consensus on optimal treatment of deep partial-thickness (second-degree) burns has emerged, as reflected by the wide variability in available wound-care materials. The relative efficacies of products used for treatment of partial-thickness thermal burns remain unclear. Mesotherapy features intradermal administration of various agents, depending on burn location. In the present experimental study, we explored the efficacy of mesotherapy used to treat partial-thickness thermal burns in 50 male Wistar rats divided into five groups of equal number. No procedure was performed after infliction of thermal burns in control group (Group 1). Mesotherapy was applied with physiological saline in sham group (Group 2), glutathione, taurine, and l-carnitine were separately applied in Group 3, Group 4, and Group 5, respectively.

Materials and methods

Mesotherapeutic agents were injected intradermally into the reticular layer of the dermis using the point technique. The first course of mesotherapy was given within the first 2 h after infliction of thermal burns, and therapy was continued to day 10. On day 22, unhealed thermal burn areas were measured prior to sacrifice, and biopsies covering the total areas of burns were performed to allow of pathological evaluation.

Results

Group 3 (the glutathione group) showed the best extent of healing, followed by Group 4 (the taurine group) and Group 5 (the l-carnitine group). The healed thermal burn areas in these groups were significantly greater than those in the control and sham groups (P = 0.001). All of healing, acute and chronic inflammation, the amount of granulation tissue, the level of fibroblast maturation, the amount of collagen, the extent of re-epithelization and neovascularization, and ulcer depth were scored upon pathological examination of tissue cross-sections. The best outcomes were evident in the glutathione group, with statistical significance. Although wound healing in the l-carnitine and taurine groups was better than in the control and sham groups, the differences were not statistically significant.

Conclusion

Thus, glutathione mesotherapy was effective when used to treat partial-thickness thermal burns and may be a useful treatment option for various human burns.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1
Fig. 2
Fig. 3
Fig. 4
Fig. 5

Similar content being viewed by others

References

  1. Kuyumcu M, Şen H, Özkan S. Anesthesia in Burn Injury Patients. TAF Prev Med Bull. 2011;10(3):351–60.

    Article  Google Scholar 

  2. Griffs RW. Management of multiple casualties with burns. BMJ. 1985;291:917–8.

    Article  Google Scholar 

  3. Zor F, Ersöz N, Külahçı Y, Kapı E, Bozkurt M. Gold standards for primary care of burn management. Dicle Med J. 2009;36(3):219–25.

    Google Scholar 

  4. Kahn SA, Patel JH, Lentz CW, et al. Firefighter Burn injures: predictable patterns influenced by Turnout Gear. J Burn Care Res. 2012;33(1):152–6.

    Article  PubMed  Google Scholar 

  5. Schwarze H, Küntsher M, Uhling C, Hierlemann H, Prantl L, Ottomann C, Hartmann B. Suprathel a new skin substitue, in the management of partial-thickness burn wounds. Ann Plast Surg. 2008;60:181–5.

    Article  CAS  PubMed  Google Scholar 

  6. Atiyeh BS, Gun SW, Hayek SN. State of the art in burn treatment. World J Surg. 2005;29:131–48.

    Article  PubMed  Google Scholar 

  7. Haik J, Ashkenazy O, Sinai S, et al. Burn care standards in israel: lack of concensus. Burns. 2005;31:845–9.

    Article  CAS  PubMed  Google Scholar 

  8. Caruso DM, Foster KN, Hermans MHE, Rick C. Aquacel Ag in the management of partial-thickness burns: results of a clinical trial. J Burn Care Rehabil. 2004;25:89–97.

    Article  PubMed  Google Scholar 

  9. Lefbaschoff G, Steher D. Mesotherapy in the treatment of cellulite. In: Goldman MP, Balci PA, Leibaschoff G, Hexel D, Angelini F, editors. Cellulite pathophysichology and treatment. New York: Taylor & Francis Group; 2006. p. 263–86.

    Google Scholar 

  10. Rohrich RJ. Mesotherapy: what is it? Does it work? Plast Reconstr Surg. 2005;115(5):1425.

    Article  CAS  PubMed  Google Scholar 

  11. Caruso MK, Roberts AT, Bissoon L, et al. An evolution of mesotherapy solutions for inducing lipolysis and trating cellulite. J Plast Reconstruct Aesthet Surg. 2008;61(11):1321–4.

    Article  Google Scholar 

  12. Atiyeh Bishara S, İbrahim Amir E, Dibo Saad A. Cosmetik mesotherapy: between Scientitic Cuidince. Science, fiction and lucrative busines Aesth plast Surg. 2008;32:842–9.

    Article  Google Scholar 

  13. Larizzo M, De Padava MP, Tosti A. Mesotherapi in sken rejuvenation. In: Tosti A, De Padova MP, editors. Atlas of mesotherapy in skin rejuvenation. London: Informa UK Ltd; 2007. p. 1–8.

    Google Scholar 

  14. Mysore V. Mesotherapy in Management of Hairloss—Is it of Any Use? . Int J Tricholoji. 2010;2(4):45–6.

    Article  Google Scholar 

  15. Vedamurthy M. Mesotherapy. Indian J. Dermatol Venerol Lepral. 2007;73(1):60–2.

    Article  Google Scholar 

  16. Farriol M, Rosello J, Schwarz S. Body surface area in sprague—Dowley Rats. J Anim physial A Anim Nutr. 1997;77:61–5.

    Article  Google Scholar 

  17. Abramov Y, Golden B, Sullivan M, Botros SM, Miller J-JR, Alshahrour A, Goldberg RP, Sand PK. Histologic characterization of vaginal vs. abdominal surgical wound healing in rabbit model. Wound Rep Reg. 2007;15:80–6.

    Article  Google Scholar 

  18. Murray CJL, Lopez AD editors. The global burden of disease: a comprehensive assessment of mortality an disability from diseases, injuries and risk factors in 1990 and projected to 2020, vol 1. Boston, MA, USA: World Health Organization; 1996.

  19. Yılmaz S, Sezer RE, Karagöz N, Erçöçen AR, Sezer H, et al. Sivas’ta alan taramasıyla yanık insidansının araştırılması. Türkiye Klinikleri. J Med Sci. 2010;30(5):1552–60.

    Google Scholar 

  20. Avşaroğulları L, Sözüer E, İkizceli İ, Kekeç Z, Yürümez Y, Özkan S. Adult burn injuries in an emergency department in central Anatolia, Turkey: a 5-year analysis. Burn. 2003;29:571–7.

    Article  Google Scholar 

  21. Salmanpakoğlu N. Yanıklar ve Tedavileri. GATA Basımevi Ankara; 1998. s. 11.

  22. Hettiaratchy S, Dziewulski P. ABC of burns. BMJ. 2004;328:1366–8.

    Article  PubMed  PubMed Central  Google Scholar 

  23. Pistor M. What is mesotherapy? Chir dest Fr. 1976;46(288):59–60.

    CAS  Google Scholar 

  24. Rotunda AM, Kolodney MS. Mesotherapy and phosplasticdylcholtne injections: historical claritication and review. Dermatol Surg. 2006;32(4):465–80.

    CAS  PubMed  Google Scholar 

  25. Meskes CJ, Laoussadi S, Kac-Ohana N, Laseire O. Contralled trial of injektable diclotenal in mesotherapy fort he treatment of tendinitis. Rev Rhum Mal osteoartic. 1990;57(7):589–91.

    Google Scholar 

  26. Aurust SD, Thomas CE, Morehouse LA, Saito M, Bucher JR. Active oxygen and toxicity. Adv Exp Med Biol. 1986;197:513–26.

    Article  Google Scholar 

  27. Şener G, Şehirli AO, Şatıroğlu H, Keyer-Uysal M, Yeğen C. Melatonin improves oxidative organ damage in a rat model of thermal injury. Burns. 2002;28:419–25.

    Article  PubMed  Google Scholar 

  28. Şehirli AO, Şener G, Şatıroğlu H, Ayanoğlu-Dülger G. Protective effect of N-acetylcysteine on renal ischemia/reperfüsyon injury in rat. J Nephrol. 2003;16:75–8.

    PubMed  Google Scholar 

  29. Arrigo AP. Gene expression and the thiol redox state. Free Radic Biol Med. 1999;27:936–44.

    Article  CAS  PubMed  Google Scholar 

  30. Youn YK, Suh GJ, Jung SE, Oh SK, Demling R. Recombinant human growth hormone decreases lung and liver tissue lipid peroxidation and increases antioxsidant activity after thermal injury in rats. J Burn Care Rehabil. 1998;19:548.

    Article  Google Scholar 

  31. Youn YK, LaLonde C, Demling R. Oxidant and the pathophysiology of burn and smoke inhalation injury. Free Radic Biol Med. 1992;12:409–15.

    Article  CAS  PubMed  Google Scholar 

  32. Nguyen TT, Cox CS, Traber DL, Gasser H, Redl H, Schlag G, et al. Free radical activity and loss of plasma antioxidants, vitamin E and sulfhydryl groups in patients with burns: the 1993 Moyer Award. J Burn Care Rehabil. 1993;14:602–9.

    Article  CAS  PubMed  Google Scholar 

  33. LaLonde C, Nayak U, Hennigan J, Demling RH. Excessive liver oxidant stress causes mortality in response to burn injury combined with endotoxin and is prevented with antioxidants. J Burn Care Rehabil. 1997;18:187–92.

    Article  CAS  PubMed  Google Scholar 

  34. Parihar A, Parihar MS, Milner S, Bhat S. Oxidative stres and antioxidative mobilization in burn injury. Burns. 2008;34:6–17.

    Article  PubMed  Google Scholar 

  35. Militante J, Lombardini JB. Age related retinal degeneration in animal models of aging: possible involuement of tourine deficiency and oxidative stress. Neurochem Res. 1996;29(1):84–6.

    Google Scholar 

  36. Militante JD, Lombardini JB. Treatment of hypertension with oral tourine: experimental and clinical studies. Amino Acids. 2002;23(4):381–93.

    Article  CAS  PubMed  Google Scholar 

  37. Knoll B. Bildatlas der ästhetischen Mesotherapie wirkstoffe/dosierung/Anwendung. Berlin: KVM; 2010. p. 3–4.

  38. Kargı E, Deren O, Babucçu O, Hoşnuter M, Erdoğan B. Dual synergistic effect: the effect of dexamethasone plus carnitine on skin flap survival. Ann Plast Surg. 2004;53:488–91.

    Article  PubMed  Google Scholar 

  39. Deveci M, Öztürk S, Bayram Y, Aydın A, Eken A, Şengezer M. Diyabetik yaraların tedavisinde topikal glutatyon uygulaması. Turk Plast Surg. 2005;13(3):179–84.

    Google Scholar 

  40. Vaalamo M, Leivo T, Saarialho-Kere U. Differential expression of tissueinhibitors of metalloproteinases (TIMP-1, -2, -3, and -4) in normal and aberrant wound healing. Hum Pathol. 1999;30:795–802.

    Article  CAS  PubMed  Google Scholar 

  41. Vaalamo M, Mattila L, Iohansson N, et al. Distinct populations of stromal cells express collagenase-3 (MMP-13) and collagenase-1 (MMP-1) in chronic ulcers but not in normally healing wounds. J Invest Dermatol. 1997;109:96–101.

    Article  CAS  PubMed  Google Scholar 

  42. Grinell F, Zhu M. Fibronectin degradation in chronic wounds dependson the relative levels of elastase, alpha1-proteinase inhibitor, and alpha2-macroglobulin. J Invest Dermatol. 1996;106:335–41.

    Article  Google Scholar 

  43. Shandall AA, Williams GT, Hallet MB, et al. Colonic healing: a role for polymorphonuclear leucocytes and oxygen radical production. Br J Surg. 1986;73:225–8.

    Article  CAS  PubMed  Google Scholar 

  44. Mallya SK, Mookhtiar KA, Gao Y, et al. Characterization of 58-kilodalton human neutrophil collagenase: comparison with human fibroblast collagenase. Biochemistry. 1990;29:10628–34.

    Article  CAS  PubMed  Google Scholar 

  45. Punch J, Rees RS, Cashmer B, et al. Xanthine oxidase: its role in no-reflow phenomenon. Surgery. 1992;111:169–76.

    CAS  PubMed  Google Scholar 

  46. Wilkens EW, Rees R, Smith D, et al. Identification of xanthine oxidase activity following reperfusion in human tissue. Ann Plast Surg. 1993;31:60–5.

    Article  Google Scholar 

  47. Upadhya GA, Strasberg SM. Glutathione, lactobionate, and histidine: cryptic inhibitors of matrix metalloproteinases contained in University of Wisconsin and histidine/tryptophan/ketoglutarate liver preservation solutions. Hepatology. 2000;31:1115–22.

    Article  CAS  PubMed  Google Scholar 

  48. Kopal C, Deveci M, Ozturk S, Sengezer M. Effects of topical glutathione treatment in rat ischemic wound model. Ann Plast Surg. 2007;58(4):449–55.

    Article  CAS  PubMed  Google Scholar 

  49. Tintinalli JE. Emergency Medicine. A Comprehensive Study Guide (Emergency Medicine (Tintinalli)). New York: McGraw-Hill Companies; 2010. p. 1374–86.

    Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to T. Görgülü.

Ethics declarations

Conflict of interest

The authors Ayhan Buz, Tahsin Görgülü, Abdulkerim Olgun, and Eksal Kargi declare that they have no conflict of interest.

Compliance with ethical requirements

The study was approved by the Animal Experiments Local Ethical Committee of the Bulent Ecevit University prior to initiation, and appropriate protocols were followed. The research was conducted in the experimental laboratory of the Medical Faculty of Bulent Ecevit University. All experimental protocols conformed to international regulations and declarations relevant to animal experimentation. Ethical Committee Approval Number: 2010-15-27/05.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Buz, A., Görgülü, T., Olgun, A. et al. Efficacy of glutathione mesotherapy in burns: an experimental study. Eur J Trauma Emerg Surg 42, 775–783 (2016). https://doi.org/10.1007/s00068-015-0607-8

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00068-015-0607-8

Keywords

Navigation